The University of California, Irvine (UCI) implemented and tested a CVD risk assessment tool that immediately identifies patients who are at increased risk for CVD or developing CVD. This tool can be integrated into the electronic health record (EHR) system.
This measure identifies patients with deep vein thrombosis (DVT) on anticoagulation for at least 3 months after the diagnosis
Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period
Percent of patients who were screened for depression (using a standardized depression screening tool) at start or resumption of home health care
The percentage of adolescent patients (12 to 17 years of age) and adult patients (18 years of age or older) with a diagnosis of major depression or dysthymia who have a completed PHQ-9 or PHQ-9M tool during a four month measurement period.
The percentage of adolescents 13 years of age who had a screening for depression using a standardized tool.
The percentage of adolescents 18 years of age who had a screening for depression using a standardized tool.
The percentage of children screened for risk of developmental, behavioral and social delays using a standardized screening tool in the first three years of life. This is a measure of screening in the first three years of life that includes three, age-specific indicators assessing whether children are screened by 12 months of age, by 24 months of age and by 36 months of age.